Pharmacological effects of vitamin D and its analogs: Recent developments

Drug Discovery Today

Volumn 19, Issue 11, 2014, Pages 1769-1774

  Sintov, Amnon C ^a   Yarmolinsky, Ludmilla ^a   Dahan, Arik ^a   Ben Shabat, Shimon ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; COLECALCIFEROL; VITAMIN D; VITAMIN D DERIVATIVE; ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT;

ACNE; ANTIDIABETIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ATOPIC DERMATITIS; BONE METABOLISM; CALCIUM ABSORPTION; CALCIUM HOMEOSTASIS; CANCER PREVENTION; CANCER THERAPY; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DRUG TARGETING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PSORIASIS; REVIEW; ROSACEA; SKIN DISEASE; VITILIGO; ANALOGS AND DERIVATIVES; ANIMAL; BONE; METABOLISM; NEOPLASMS;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE AND BONES; CALCIUM; HUMANS; HYPOGLYCEMIC AGENTS; MULTIPLE SCLEROSIS; NEOPLASMS; SKIN DISEASES; VITAMIN D;

EID: 84910670232     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.06.008     Document Type: Review

References (79)

1. N. Radlovic Vitamin D in the light of current knowledge Srp. Arch. Celok. Lek. 140 2012 110 114
2. J. Lu Transcriptional profiling of keratynocytes reveals a vitamin D-regulated differentiation network J. Invest. Dermatol. 124 2005 778 785
3. L. Leiben Calcemic actions of vitamin D: effects on the intestine, kidney and bone Best Pract. Res. Clin. Endocrinol. Metab. 25 2011 561 572
4. S.T. Armand, and R.P. Naja Vitamin D metabolism, cartilage and bone fracture repair Mol. Cell. Endocrinol. 347 2011 48 54
5. M. Peacock Calcium metabolism in health and disease Clin. J. Am. Soc. Nephrol. 5 2010 523 530
6. J.T. Potts, and T.J. Gardella Progress, paradox and potential: parathyroid hormone research over five decades Ann. N. Y. Acad. Sci. 1117 2007 196 208
7. P.W. Jurutka Molecular nature of vitamin D receptor and its role in regulation of gene expression Rev. Endocr. Metab. Disord. 2 2001 203 216
8. E.M. Brown The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics Subcell. Biochem. 45 2007 139 167
9. A. Gehak In vitro studies on intestinal calcium and phosphate transport in horses Comp. Biochem. Physiol. A Mol. Integr. Physiol. 161 2012 259 264
10. S.T. Armand, and R.P. Naja Vitamin D metabolism, cartilage and bone fracture repair Mol. Cell Endocrinol. 347 2011 48 54
11. S. Geng Vitamin D metabolism in human bone marrow stromal (mesenchymal stem) cells Metabolism 62 2013 768 777
12. G.J. Atkins RANKL expression is related to the differentiation state of human osteoblasts J. Bone Miner. Res. 18 2003 1088 1096
13. Y. Yamamoto Vitamin D receptor in osteoblasts is a negative regulator of bone mass control Endocrinology 154 2013 1008 1020
14. G.J. Atkins Metabolism of vitamin D(3) in human osteoblasts: evidence for autocrine and paracrine activities of 1alpha, 25-dihydroxyvitamin D(3) Bone 40 2007 1517 1528
15. D. Bikle Vitamin D and the skin physiology and pathophysiology Rev. Endocr. Metab. Disord. 13 2012 3 19
16. D.E. Prosser, and G. Jones Enzymes involved in the activation and inactivation of vitamin D Trends Biochem. Sci. 29 2004 664 673
17. H.F. Luderer, and M.B. Demay The vitamin D receptor, the skin and stem cells J. Steroid Biochem. Mol. Biol. 121 2010 314 316
18. D.A. Youssef Antimicrobial implications of vitamin D Demaloendocrinology 3 2011 220 229
19. M. Reinholz, and J. Schauber Vitamin D and innate immunity of the skin Dtsch. Med. Wochenschr. 137 2012 2385 2389
20. L. Adorini Toloregenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes Ann. N. Y. Acad. Sci. 988 2003 257 261
21. H.C. Wulf The relation between skin disorders and vitamin D Br. J. Dermatol. 166 2012 471 473
22. J. Reichrath Vitamin D and the skin: an ancient friend, revisited Exp. Dermatol. 16 2007 618 625
23. S. Ben-Shabat Vitamin D3-based conjugates for topical treatment of peoriasis: synthesis, antiproliferative activity, and cutaneous penetration studies Pharm. Res. 22 2005 50 58
24. J.L. O'Neill, and S.R. Feldman Vitamin D analogue-based therapies for psoriasis Drugs Today 46 2010 351 360
25. L. Trémezaygues, and J. Reichrath Vitamin D analogs in the treatment of psoriasis: where are we standing and where will we be going? Dermatoendocrinology 3 2011 180 186
26. P.L. McCormack Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp Drugs 16 2011 709 730
27. M. Oquendo Topical vitamin D analogs available to treat psoriasis Skinmed 10 2012 301 304
28. S. Devaux Adherence to topical treatment in psoriasis: a systematic literature review J. Eur. Acad. Dermatol. Venereol. 3 2012 61 67
29. L. Binderup, and E. Bramm Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo Biochem. Pharmacol. 37 1988 889 895
30. N. Kubodera A new look at the most successful prodrugs for active vitamin D (D hormone): alfacalcidol and doxercalciferol Molecules 14 2009 3869 3880
31. A. Gurlek Modulation of growth factor/cytokine synthesis and signaling by 1alpha, 25-dihydroxyvitamin D(3): implications in cell growth and differentiation Endocr. Rev. 23 2002 763 786
32. E. Sato-Deguchi Topical vitamin D3 analogues induce thymic stromal lymphopoietin and cathelicidin in psoriatic skin lesions Br. J. Dermatol. 167 2012 77 84
33. A. Balato Interleukin-1 family members are enhanced in psoriasis and suppressed by vitamin D and retinoic acid Arch. Derm. Res. 305 2013 255 262
34. A.S. Paller Latest approaches to treating atopic dermatitis Chem. Immunol. Allerg. 96 2012 132 140
35. C.C. Geilen 1α,25-Dihydroxyvitamin D3 induces sphingomyelin hydrolysis in HaCaT cells via tumor necrosis factor alpha J. Biol. Chem. 272 1997 8997 9001
36. H. Fujita The direct action of 1alpha, 25(OH)2-vitamin D3 on purified mouse Langerhans cells Cell Immunol. 245 2007 70 79
37. D.D. Bickle Differential regulation of epidermal function by VDR coactivators J. Steroid Biochem. Mol. Biol. 121 2010 308 313
38. N.J. Nieves Identification of a unique subset of 2-methylene-19-nor analogs of vitamin D with comedolytic activity in the rhino mouse J. Invest. Derm. 130 2010 2359 2367
39. D.M. Freedman Prospective study of serum vitamin D and cancer mortality in the United States J. Natl. Cancer Inst. 99 2007 1594 1602
40. T. Shao Vitamin D and breast cancer Oncologist 17 2012 36 45
41. L. Berkovich Induction of apoptosis and inhibition of prostate and breast cancer growth by BGP-15, a new calcipotriene-derived vitamin D3 analog Anticancer Drugs 21 2010 609 618
42. M. Milczarek Synthesis and biological activity of diastereomeric and geometric analogs of calcipotriol, PRI-2202 and PRI-2205, against human HL-60 leukemia and MCF-7 breast cancer cells Cancers (Basel) 5 2013 1355 1378
43. L. Berkovich Inhibition of cancer growth and induction of apoptosis by BGP-13 and BGP-15, new calcipotriene-derived vitamin D3 analogs, in vitro and in vivo studies Invest. New Drugs 31 2013 247 255
44. T. Vink-van Wijngaarden Inhibition of insulin and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089 Eur. J. Cancer 5 1996 842 848
45. Q. Wang 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death Cancer Res. 60 2000 2040 2048
46. C.L. Richard Involvement of 1,25D3-MARRS (membrane associated, rapid response steroid-binding), a novel vitamin D receptor, in growth inhibition of breast cancer cells Exp. Cell Res. 316 2010 695 703
47. K. Nakagawa 1α,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer Carcinogenesis 26 2005 429 440
48. Q. Zhang CYP24 inhibition preserves 1α,25-dihydroxyvitamin D(3) anti-proliferative signaling in lung cancer cells Mol. Cell Endocrinol. 355 2012 153 161
49. Y. Ma 1α,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model Mol. Cancer Ther. 7 2008 3047 3055
50. A.Y. Slominski 20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells Am. J. Physiol. Cell Physiol. 300 2011 526 541
51. Y. Ma 1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models Cancer 116 2010 3294 3303
52. X. Zhang Vitamin D receptor is a novel drug target for ovarian cancer treatment Curr. Cancer Drug Targets 3 2006 229 244
53. R.G. Moore Efficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft model PloS One 7 2012 3143 3150
54. W.L. Wang 1,25-Dihydroxyvitamin D(3) modulates lipid metabolism in prostate cancer cells through miRNA mediated regulation of PPARA J. Steroid Biochem. Mol. Biol. 136 2012 247 251
55. M. Stio The novel vitamin D analog ZK191784 inhibits prostate cancer cell invasion Anticancer Res. 31 2011 4091 4098
56. V. Bhatia EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells Mol. Cancer Ther. 8 2009 1787 1798
57. M. Milczarek Combined colonic cancer treatment with vitamin D analogs and irinotecan or oxaliplatin Anticancer Res. 33 2013 433 444
58. G. Jones Pharmacokinetics of vitamin D toxicity Am. J. Clin. Nutr. 88 2008 582 586S
59. S. Eduardo-Canosa Design and synthesis of active vitamin D analogs J. Steroid Biochem. Mol. Biol. 12 2010 7 12
60. F.S. Cheung Current progress in using vitamin D and its analogs for cancer prevention and treatment Expert Rev. Anticancer Ther. 6 2012 811 837
61. T.M. Beer Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT investigators J. Clin. Oncol. 6 2007 669 674
62. S.H. Kim Characterization of vitamin D receptor (VDR) in lung adenocarcinoma Lung Cancer 77 2012 265 271
63. G.M. Zinser, and J. Welsh Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice Carcinogenesis 12 2004 2361 2372
64. C.M. Kemmis, and J. Welsh Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway J. Cell Biochem. 105 2008 980 988
65. N. Nemazannikova Role of vitamin D metabolism in cutaneous tumour formation and progression J. Pharm. Pharmacol. 65 2013 2 10
66. D. Matthews Genomic vitamin D signaling in breast cancer: insights from animal models and human cells J. Steroid Biochem. Mol. Biol. 121 2010 362 367
67. C.J. Narawaez, and J. Welsh Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells J. Biol. Chem. 276 2001 9101 9107
68. A.V. Krishnan The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer Steroids 77 2012 1107 1112
69. C.K. Chakraboiti Vitamin D as a promising anticancer agent Indian J. Pharmacol. 43 2011 113 120
70. M. Danilenko Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1alpha, 25-dihydroxyvitamin D3 in leukemia cells but does not promote elevation of basal levels of intracellular calcium Cancer Res. 63 2003 1325 1332
71. P. Manna, and S.K. Jain Vitamin D up-regulates glucose transporter 4 (GLUT4) translocation and glucose utilization mediated by cystathionine-γ-lyase (CSE) activation and H2S formation in 3T3L1 adipocytes J. Biol. Chem. 287 2012 42324 42332
72. C.M. Kiekhaefer 2α-Methyl-19-nor-(20S)-1,25-dihydroxyvitamin D(3) protects the insulin 2 knockout non-obese diabetic mouse from developing type 1 diabetes without hypercalcaemia Clin. Exp. Immunol. 166 2011 325 332
73. M.F. Holick Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis Am. J. Clin. Nutr. 79 2004 362 371
74. A.G. Pittas The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults Diabetes Care 30 2007 980 986
75. B. Pozuelo-Moyano, and J. Benito-Leon Vitamin D and multiple sclerosis Rev. Neurol. 56 2013 243 251
76. G.S. Slavov Vitamin D immunomodulatory potential in multiple sclerosis Folia Med. (Plovdiv) 55 2013 5 9
77. A. Dahan, and A. Hoffman Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs Eur. J. Pharm. Sci. 24 2005 381 388
78. A. Dahan, and A. Hoffman Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: correlation with in vivo data and the relationship to intra-enterocyte processes in rats Pharm. Res. 23 2006 2165 2174
79. A. Dahan The oral absorption of phospholipid prodrugs: in vivo and in vitro mechanistic investigation of trafficking of a lecithin-valproic acid conjugate following oral administration J. Control. Release 126 2008 1 9